Search Results - "Lotesoriere, Claudio"

Refine Results
  1. 1

    Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines by Refolo, Maria Grazia, Lotesoriere, Claudio, Lolli, Ivan Roberto, Messa, Caterina, D’Alessandro, Rosalba

    Published in Scientific reports (28-04-2020)
    “…Ramucirumab is approved both as monotherapy and in combination with Paclitaxel for advanced gastric cancer in patients with disease progression after…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Hepatitis C Virus Infection Involves CD34+Hematopoietic Progenitor Cells in Hepatitis C Virus Chronic Carriers by Sansonno, Domenico, Lotesoriere, Claudio, Cornacchiulo, Vito, Fanelli, Massimo, Gatti, Pietro, Iodice, Giuseppe, Racanelli, Vito, Dammacco, Franco

    Published in Blood (01-11-1998)
    “…Although hepatitis C virus (HCV) mainly affects hepatocytes, infection is widespread and involves immunologically privileged sites. Whether lymphoid cells…”
    Get full text
    Journal Article
  11. 11

    Integrated immune gene expression signature and molecular classification in gastric cancer: New insights by Refolo, Maria Grazia, Lotesoriere, Claudio, Messa, Caterina, Caruso, Maria Gabriella, D'Alessandro, Rosalba

    Published in Journal of leukocyte biology (01-08-2020)
    “…Gastric cancer (GC) is characterized by extreme heterogeneity due to histopathological differences, molecular characteristics, and immune gene expression…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications by Ricci, Angela Dalia, Rizzo, Alessandro, Schirizzi, Annalisa, D'Alessandro, Rosalba, Frega, Giorgio, Brandi, Giovanni, Shahini, Endrit, Cozzolongo, Raffaele, Lotesoriere, Claudio, Giannelli, Gianluigi

    Published in Cancers (20-10-2024)
    “…Treatment options for intrahepatic cholangiocarcinoma (iCCA), a highly malignant tumor with poor prognosis, are limited. Recent developments in immunotherapy…”
    Get full text
    Journal Article
  15. 15

    Durvalumab in advanced cholangiocarcinoma: is someone knocking down the door? by Ricci, Angela Dalia, D'Alessandro, Rosalba, Rizzo, Alessandro, Schirizzi, Annalisa, Vallarelli, Simona, Ostuni, Carmela, Troiani, Laura, Lolli, Ivan Roberto, Lotesoriere, Claudio, Giannelli, Gianluigi

    Published in Immunotherapy (01-05-2023)
    “…Following the practice-changing results observed in several hematological and solid tumors, immunotherapy with immune checkpoint inhibitors (ICIs) has been…”
    Get full text
    Journal Article
  16. 16

    Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report by Lolli, Ivan, Stasi, Elisa, Fucilli, Fabio, Pirrelli, Michele, Armentano, Raffaele, Campanella, Giovanna, Lotesoriere, Claudio, Lorusso, Dionigi

    Published in Medicine (Baltimore) (01-06-2017)
    “…Pancreatic neuroendocrine tumors (PNETs) account for less than 5% of all pancreatic tumors. PNETs develop from pancreatic endocrine islet cells and have a…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20